Stay updated on Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    Change Detected
    Summary
    The study has been updated to version v2.10.0, with two locations now included, replacing the previous version v2.9.7.
    Difference
    0.3%
    Check dated 2024-07-23T15:09:20.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated to Revision v2.9.7 from v2.9.6.
    Difference
    0.1%
    Check dated 2024-07-16T08:19:56.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-07-02T15:22:51.000Z thumbnail image
  8. Check
    30 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-27T11:17:47.000Z thumbnail image
  9. Check
    31 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent revision in the content of the web page.
    Difference
    0.1%
    Check dated 2024-06-26T09:53:54.000Z thumbnail image
  10. Check
    32 days ago
    Change Detected
    Summary
    The value 'Show more Show more Revision: v2.9.0' has been updated to 'Show less Genetic and Rare Diseases Information Center resources: Adrenocortical Carcinoma Adrenal Cancer Drug Information available for: Cabozantinib Cabozantinib s-malate FDA Drug and Device Resources Show less'. This change indicates a shift in the displayed information from showing more details to showing less, specifically focusing on genetic and rare diseases information related to Adrenocortical Carcinoma and Adrenal Cancer.
    Difference
    9%
    Check dated 2024-06-25T08:55:02.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Advanced Adrenocortical Carcinoma Clinical Trial page.